Skip to main navigation Skip to search Skip to main content

Cost of illness, cost of immunoglobulin therapy and their determinants in chronic inflammatory demyelinating polyneuropathy

Research output: Contribution to journal › Letter, comment/opinion or interview › peer-review

Original languageEnglish
Pages (from-to)E22
JournalMuscle and Nerve
Volume59
Issue number3
DOIs
Publication statusPublished - 1 Mar 2019

Cite this